GlassScriptPhysician profile
Berry Fairchild
NPI 1801215512
$10,339.13
in general payments reported to CMS, 2019-2025
13 companies · $5,291 in 2025
The $5,291 reported for 2025 was more than what 93% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2020: $303 · 2021: $869 · 2022: $1,379 · 2023: $508 · 2024: $1,619 · 2025: $5,291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,375 · Consulting Fee: $2,500 · Travel and Lodging: $1,369 · Gift: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,375.09 |
| Consulting Fee | $2,500.00 |
| Travel and Lodging | $1,369.10 |
| Gift | $174.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motiva USA, LLC | $3,873.51 | 2024-2025 | |
| Allergan, INC. | $2,530.98 | 2019-2022 | |
| Mentor Worldwide LLC | $2,281.96 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Mentor Memorygel Breast Implant |
| Abbvie INC. | $857.09 | 2023-2025 | |
| Galderma Laboratories, L.P. | $389.48 | 2019-2025 | |
| Davol INC. | $124.70 | 2022 | |
| Medical Device Business Services, INC. | $67.75 | 2022-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Rti Surgical, INC | $67.29 | 2022 | |
| Alafair Biosciences, INC. | $63.15 | 2022-2025 | Versawrap |
| Integra Lifesciences Corporation | $28.92 | 2023 | Durasorb Monofilament Mesh |
| Revance Therapeutics, INC. | $20.93 | 2025 | Daxxify |
| Olympus America INC. | $16.74 | 2023 | |
| Acelrx Pharmaceuticals, INC. | $16.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Berry Fairchild listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.